One key group includes individuals who arent looking for weight loss but want to support their metabolic health, manage chronic inflammation, or take a proactive approach to disease prevention and longevity
Those who received the GLP-1 infusion were found to consume 12 percent fewer calories than those hooked up to just saline (Flint, Raben, Astrup)
Khan et al., 2024) if nutritional and behavioural supports are not intensified (Sievenpiper 2026)
Since then, others have been made, including: Liraglutide (Victoza for diabetes, Saxenda for weight loss) Dulaglutide (Trulicity), Lixisenatide (Adlyxin) Semaglutide (Ozempic, Wegovy, and Rybelsus, which is a tablet) Tirzepatide (Mounjaro and Zepbound) works on two gut hormones, not just GLP1
The FDA has acknowledged this reality on the label itself: weight care requires ongoing therapy , and GLP-1 drugs are approved for chronic weight management only as an adjunct to diet and exercise they are not magic bullets that cure obesity after a few doses
Rapid weakness, severe fatigue, confusion, or inability to eat enough
